Allogene Therapeutics annual operating margin
2021
2022
2023
2024
Allogene Therapeutics Operating Margin Growth & History (ALLO)
Allogene Therapeutics's operating margin was −1,241,813.64% for fiscal 2024.
View full Allogene Therapeutics company overviewAllogene Therapeutics annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | −1,241,813.64% | −896827.32 pp |
| 2023 | 2023-12-31 | −344,986.32% | −129899.14 pp |
| 2022 | 2022-12-31 | −215,087.18% | −214929.24 pp |
| 2021 | 2021-12-31 | −157.94% | — |
Allogene Therapeutics quarterly operating margin
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −1,011.21% | +365079.70 pp |
| Q1 2024 | 2024-03-31 | −315,927.27% | +14379.39 pp |
| Q4 2023 | 2023-12-31 | −405,280.95% | −236936.05 pp |
| Q3 2023 | 2023-09-30 | −286,345.45% | −197282.66 pp |
| Q2 2023 | 2023-06-30 | −366,090.91% | −234956.48 pp |
| Q1 2023 | 2023-03-31 | −330,306.67% | −330308.92 pp |
| Q3 2022 | 2022-09-30 | −168,344.90% | −9834.69 pp |
| Q2 2022 | 2022-06-30 | −89,062.79% | +72366.75 pp |
| Q1 2022 | 2022-03-31 | −131,134.43% | −131047.84 pp |
| Q4 2021 | 2021-12-31 | 2.26% | — |
| Q3 2021 | 2021-09-30 | −158,510.20% | — |
| Q2 2021 | 2021-06-30 | −161,429.55% | — |
| Q1 2021 | 2021-03-31 | −86.58% | — |
Allogene Therapeutics operating margin trends
Across the available reported history, Allogene Therapeutics's operating margin decreased from −344,986.32% to −1,241,813.64%, a change of −896827.32 percentage points. The latest reported quarter, Q2 2026, shows −1,011.21%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Allogene Therapeutics filings at SEC.gov ↗